Witnessing the stock’s movement on the chart, on November 05, 2021, Jaguar Health Inc. (NASDAQ: JAGX) had a quiet start as it plunged -3.79% to $2.03. During the day, the stock rose to $2.12 and sunk to $1.985 before settling in for the price of $2.11 at the close. Taking a more long-term approach, JAGX posted a 52-week range of $0.56-$13.41.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 105.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 88.90%. This publicly-traded company’s shares outstanding now amounts to $44.81 million, simultaneously with a float of $40.90 million. The organization now has a market capitalization sitting at $98.11 million. At the time of writing, stock’s 50-day Moving Average stood at $2.37, while the 200-day Moving Average is $4.62.
Let’s gauge the efficiency of the firm, which has a total of 34 employees. It has generated 276,029 per worker during the last fiscal year. Meanwhile, its income per employee was -994,382. The stock had 3.00 Receivables turnover and 0.24 Total Asset turnover. For the Profitability, stocks gross margin was +65.05, operating margin was -283.93 and Pretax Margin of -360.25.
Jaguar Health Inc. (JAGX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Jaguar Health Inc.’s current insider ownership accounts for 0.70%, in contrast to 22.40% institutional ownership. According to the most recent insider trade that took place on Jun 04, this organization’s Director sold 152 shares at the rate of 1.74, making the entire transaction reach 264 in total value, affecting insider ownership by 954,390. Preceding that transaction, on Jun 03, Company’s Director sold 292 for 1.75, making the whole transaction’s value amount to 511. This particular insider is now the holder of 954,542 in total.
Jaguar Health Inc. (JAGX) Earnings and Revenue Records
As on 6/29/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.3 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.12) by -$0.18. This company achieved a net margin of -360.25 while generating a return on equity of -179.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
Jaguar Health Inc.’s EPS increase for this current 12-month fiscal period is 88.90% and is forecasted to reach -0.60 in the upcoming year.
Jaguar Health Inc. (NASDAQ: JAGX) Trading Performance Indicators
Let’s observe the current performance indicators for Jaguar Health Inc. (JAGX). It’s Quick Ratio in the last reported quarter now stands at 3.20. The Stock has managed to achieve an average true range (ATR) of 0.17. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.02.
In the same vein, JAGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.67, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.60 at the market close of one year from today.
Technical Analysis of Jaguar Health Inc. (JAGX)
Going through the that latest performance of [Jaguar Health Inc., JAGX]. Its last 5-days volume of 1.87 million was inferior to the volume of 5.4 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 24.44% While, its Average True Range was 0.17.
Raw Stochastic average of Jaguar Health Inc. (JAGX) in the period of the previous 100 days is set at 6.23%, which indicates a major fall in contrast to 25.88% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 135.34% that was higher than 85.36% volatility it exhibited in the past 100-days period.